Screening for brain metastases in patients with advanced non-small cell lung cancer and an actionable genomic alteration: A structured literature review
{{output}}
Background: Brain metastases (BM) frequently occur in patients with non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGA). Targeted therapies (TTs) improve outcomes, but differences in BM screening and elig... ...
